多克西西丁和多克西胺:首次获得批准
1Springer Nature, Private Bag 65901, Mairangi Bay, Auckland, 0754, New Zealand. pdd@adis.com.
Paediatric drugs
|January 28, 2026
概括
多克西西丁和多克斯里布蒂明 (KYGEVVI®) 是治疗二胺基因酶2缺乏症 (TK2d) 的新疗法. 这些胺基核酸在2025年11月获得美国FDA批准,适用于符合条件的成人和儿科患者.
科学领域:
- 生物化学 生化学
- 药理学 药理学是指药理学的学科.
- 遗传学 是一个遗传学.
背景情况:
- 乙胺基因酶2缺乏症 (TK2d) 是一种罕见的线粒体DNA枯竭障碍.
- TK2d导致渐进的多系统性症状,主要影响神经肌肉功能.
- 目前TK2d的治疗选择有限,这突显了对新型治疗策略的需求.
研究的目的:
- 概述多克西西丁和多克西胺的关键发育里程碑.
- 详细说明了导致KYGEVVI®首次批准用于TK2d的监管途径.
- 为药物从开发到市场的旅程提供全面的概述.
主要方法:
- 对多克西西丁和多克西胺的临床前和临床发展数据的审查.
- 对监管提交和审批流程的分析.
- 总结了UCB对KYGEVVI®的战略发展举措.
主要成果:
- 在临床研究中,多克西西丁和多克斯里布蒂明 (KYGEVVI®) 显示出了有利的特征.
- 美国食品和药物管理局 (FDA) 在2025年11月批准了KYGEVVI®.
- 批准涵盖了TK2d的成人和儿科患者,症状在12岁时开始.
结论:
- 开发和批准多克西西丁和多克西胺代表了TK2d.治疗的重大进展.
- KYGEVVI®为患有这种使人衰弱的遗传疾病的患者提供了一种新的治疗选择.
- 这一里程碑突显了针对罕见遗传疾病的向治疗的重要性.
相关概念视频
FDA Approved Drugs: Changes to Approved Drugs
257
Post-approval, manufacturers may modify an approved new or generic drug product. Such modifications can encompass alterations in the Active Pharmaceutical Ingredient (API), manufacturing process, formulation, batch size, manufacturing site, and container closure system (FDA Guidance for Industry, April 2004). Often, a drug product may undergo multiple changes.These modifications require careful evaluation to determine their potential impact on the drug product's identity, strength, quality,...
257
Obedience
35.6K
According to obedience research, we may harm others under the forceful pressures of an authority figure (Milgram, 1974). How about if the inappropriate orders were delivered with less force? The increasing interdependence between nurses and physicians compelled Hofling and his colleagues to explore nurses’ reactions to a potentially harmful medical request made by the perceived authority figure, the doctor (Hofling, Brotzman, Dalrymple, Graves, & Pierce, 1966). In this situation,...
35.6K
Ethics in Research
25.5K
Today, scientists agree that good research is ethical in nature and is guided by a basic respect for human dignity and safety. However, this has not always been the case. Modern researchers must demonstrate that the research they perform is ethically sound.
25.5K


